Publications by authors named "Onder Kara"

Purpose: Many patients receiving intravesical BCG treatment for non-muscle-invasive bladder cancer experience high recurrence rates despite initial adequate response. In this study, the effectiveness of intravesical chemohyperthermia (CHT) with mitomycin C (MMC) was evaluated in patients who developed relapse after intravesical BCG treatment or could not tolerate the treatment and could not undergo radical cystectomy for any reason.

Materials And Methods: 59 patients who underwent complete bladder tumour resection, who had a T1 high-grade tumour and no variant histology was observed in the pathology, and who had previously received intravesical BCG treatment were included in the study.

View Article and Find Full Text PDF
Article Synopsis
  • Immunotherapy is a cancer treatment that harnesses the body's immune system to fight tumors, focusing on the tumor environment and immune mechanisms for innovation.
  • Urothelial carcinoma and renal cell carcinoma (RCC) are key areas where immunotherapies like immune checkpoint inhibitors (ICIs) have proven effective, with specific agents being used to enhance anti-tumor responses.
  • Prostate cancer, initially viewed as an "immune cold" tumor, is now increasingly targeted with immunotherapy, especially for specific cases like castration-resistant prostate cancer.
View Article and Find Full Text PDF
Article Synopsis
  • - This multi-institutional study aimed to investigate the prognostic impact of histomorphological subtyping in patients with nonmetastatic papillary renal cell carcinoma (papRCC) who underwent curative surgery, involving 1,086 patients categorized into two subtypes.
  • - Results showed that patients with type 2 papRCC were generally older, had larger tumors, and exhibited poorer survival rates, with lower 5-year recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) than type 1 patients.
  • - While type 2 was a significant predictor for RFS and CSS, it had no significant impact on OS, highlighting the need for further understanding of how these
View Article and Find Full Text PDF

Objective: To report long-term functional and oncological outcomes of OPN Methods: We enrolled 182 patients who underwent consecutive OPN with a diagnosis of kidney tumor in our clinic between April 2002 and February 2020 and were selected from our prospective OPN database. Preoperative demographic and clinical characteristics, intraoperative and pathological results, and patients' postoperative functional and oncological follow-up data were retrospectively analyzed. Overall survival (OS) and disease- free survival (DFS) were evaluated using Kaplan-Meier survival analysis.

View Article and Find Full Text PDF

Renal cell carcinoma (RCC) incidence has doubled over the past few decades. However, death rates have remained stable as the number of incidental renal mass diagnoses peaked. RCC has been recognized as a European health care issue, but to date, no screening programmes have been introduced.

View Article and Find Full Text PDF

Renal medullary carcinoma (RMC) is a rare form of renal cell carcinoma that has a poor prognosis. It is known to be associated with sickle cell trait or disease, although the exact underlying mechanisms are still unclear. The diagnosis is made through immunochemical staining for SMARCB1 (INI1).

View Article and Find Full Text PDF

An 88-year-old man was admitted to our hospital with a recurrent lower urinary tract infection. He had a history of open prostatectomy for benign prostatic hyperplasia 15 years ago and smoking. A mass arising within a bladder diverticula was suspected on the left lateral wall of the bladder on ultrasonography.

View Article and Find Full Text PDF
Article Synopsis
  • The study looked at what might cause a type of injury called urethral rupture when someone has a penile fracture.
  • They compared medical records of patients with and without the rupture to see how they did after treatment.
  • It turns out older patients are more likely to have the rupture, but fixing it doesn’t seem to create more problems or make things worse for how well they can perform later on.
View Article and Find Full Text PDF
Article Synopsis
  • The updated EAU Guidelines recommend adjuvant pembrolizumab for high-risk operable clear cell Renal Cell Carcinoma (ccRCC) but raise concerns about potential overtreatment and undertreatment of patients based on their risk levels.
  • The review highlights challenges in accurately identifying high-risk tumors due to interobserver variability among pathologists and discusses the need for better prognostic assessment systems.
  • It suggests that molecular biomarkers may improve patient prognostication in the future by helping to better identify those with a more severe prognosis.
View Article and Find Full Text PDF

Objective: The role of lymph node dissection (LND) is still controversial in patients with renal cell carcinoma undergoing surgery. We aimed to provide a comprehensive review of the literature about the effect of LND on survival, prognosis, surgical outcomes, as well as patient selection and available LND templates.

Methods: Recent literature (from January 2011 to December 2021) was assessed through PubMed and MEDLINE databases.

View Article and Find Full Text PDF

Objective: No standard strategy for diagnosis and management of positive surgical margin (PSM) and local recurrence after partial nephrectomy (PN) are reported in literature. This review aims to provide an overview of the current strategies and further perspectives on this patient setting.

Methods: A non-systematic review of the literature was completed.

View Article and Find Full Text PDF

Standard-of-care management of renal cell carcinoma (RCC) indisputably relies on surgery for low-risk localized tumours and systemic treatment for poor-prognosis metastatic disease, but a grey area remains, encompassing high-risk localized tumours and patients with metastatic disease with a good-to-intermediate prognosis. Over the past few years, results of major practice-changing trials for the management of metastatic RCC have completely transformed the therapeutic options for this disease. Treatments targeting vascular endothelial growth factor (VEGF) have been the mainstay of therapy for metastatic RCC in the past decade, but the advent of immune checkpoint inhibitors has revolutionized the therapeutic landscape in the metastatic setting.

View Article and Find Full Text PDF

Although the vast majority of prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging occurs in the field of prostate cancer, PSMA is also highly expressed on the cell surface of the microvasculature of several other solid tumors, including renal cell carcinoma (RCC). This makes it a potentially interesting imaging target for the staging and monitoring of RCC. The objective of this review is to provide an overview of the current evidence regarding the use of PSMA PET/Computed Tomography in RCC patients.

View Article and Find Full Text PDF

Purpose: To systematically review studies focused on screening programs for renal cell carcinoma (RCC) and provide an exhaustive overview on their clinical impact, potential benefits, and harms.

Methods: A systematic review of the recent English-language literature was conducted according to the European Association of Urology guidelines and the PRISMA statement recommendations (PROSPERO ID: CRD42021283136) using the MEDLINE, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov databases.

View Article and Find Full Text PDF

Objective: To evaluate the impact of Double J stent (DJS) insertion during open partial nephrectomy (OPN) on postoperative prolonged urinary leakage.

Materials And Methods: A retrospective study was made in consecutive cases of OPN performed between 2002 and 2020 for localized kidney tumors at our tertiary center. Urinary leakage was defined as drainage > 72 hours after surgery by biochemical analysis consistent with urine or radiographic evidence of urine leakage.

View Article and Find Full Text PDF

The incidental detection of renal masses has been steadily rising. As a significant proportion of renal masses that are surgically treated are benign or indolent in nature, there is a clear need for better presurgical characterization of renal masses to minimize unnecessary harm. Ultrasound is a widely available and relatively inexpensive real-time imaging technique, and novel ultrasound-based applications can potentially aid in the non-invasive characterization of renal masses.

View Article and Find Full Text PDF

Objective: Recently, VENUSS (VEnous extension, NUclear Grade, Size, Stage), as a prognostic model, was defined to predict disease recurrence (DR) after curative surgery of non-metastatic papillary renal cell carcinoma (papRCC). This study aimed to validate the VENUSS prognostic model in a large multi-institutional European cohort of patients with histopathologically proven papRCC after curative surgery for non-metastatic disease.

Patients And Methods: Overall, 980 patients undergoing partial or radical nephrectomy for sporadic, unilateral and non-metastatic papRCC between 1987 and 2020 were included from 7 European tertiary institutions.

View Article and Find Full Text PDF

Background: The purpose of this study was to assess the long-term clinical efficacy of temporary, Allium round posterior stent (RPS) used for treatment of recurrent bladder neck contracture (BNC).

Methods: Records of 42 patients with recurrent BNC who underwent Allium RPS placement after bladder neck incision, between 2009 and 2019, were analyzed. After stent removal, the success criteria for Allium RPS treatment were defined as: no evidence of stricture on urethrogram or endoscopy; more than 12 ml/sec of urinary peak flow; and no recurrent urinary tract infections.

View Article and Find Full Text PDF

Introduction: Frailty has been recognized as a major risk factor for adverse perioperative and oncological outcomes in patients with genitourinary malignancies. Yet, the evidence supporting such an association in patients with renal cell carcinoma (RCC) is still sparse. Herein we provide an updated comprehensive overview of the impact of frailty on perioperative and oncologic outcomes in patients undergoing surgery or ablation for RCC.

View Article and Find Full Text PDF